{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:18:10Z","timestamp":1761812290152,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Orthofix"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.wneu.2018.11.118","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T21:46:20Z","timestamp":1543009580000},"page":"590-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rapid Progression of Metastatic Panspinal Epidural Non\u2212Small Cell Lung Cancer After Discontinuation of Alectinib"],"prefix":"10.1016","volume":"122","author":[{"given":"Carole S.L.","family":"Spake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.C.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan H.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2018.11.118_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4\u2013ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2018.11.118_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.phrs.2017.01.007","article-title":"Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancers","volume":"117","author":"Roskoski","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.wneu.2018.11.118_bib3","first-page":"S45","article-title":"Incidence and distribution of skeletal metastases in NSCLC in the era of PET","volume":"46","author":"Kosteva","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.wneu.2018.11.118_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2007.03.013","article-title":"Skeletal metastases in non-small cell lung cancer: a retrospective study","volume":"57","author":"Tsuya","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.wneu.2018.11.118_bib5","first-page":"22","article-title":"Incidence and consequences of bone metastases in lung cancer patients","volume":"2","author":"Kuchuk","year":"2013","journal-title":"J\u00a0Bone Oncol"},{"key":"10.1016\/j.wneu.2018.11.118_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2015.04.007","article-title":"The incidence and clinical impact of bone metastases in non-small cell lung cancer","volume":"89","author":"Kuchuk","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.wneu.2018.11.118_bib7","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1158\/1078-0432.CCR-11-1468","article-title":"Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design","volume":"17","author":"Chaft","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2018.11.118_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/JTO.0b013e318257fc1d","article-title":"Disease flare after treatment discontinuation in a patient with EML4-ALK lung cancer and acquired resistance to crizotinib","volume":"7","author":"Pop","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.wneu.2018.11.118_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000354756","article-title":"Disease flare after discontinuation of crizotinib in anaplastic lymphoma kinase-positive lung cancer","volume":"6","author":"Kuriyama","year":"2013","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.wneu.2018.11.118_bib10","doi-asserted-by":"crossref","first-page":"E543","DOI":"10.21037\/jtd.2017.05.10","article-title":"Disease flare after discontinuing gefitinib in a patient with lung adenocarcinoma and concomitant epithelial growth factor receptor mutation and anaplastic lymphoma kinase translocation","volume":"9","author":"Park","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.wneu.2018.11.118_bib11","first-page":"1518","article-title":"Metastatic bone disease: diagnosis, evaluation, and treatment","volume":"91","author":"Biermann","year":"2009","journal-title":"J\u00a0Bone Joint Surg"},{"key":"10.1016\/j.wneu.2018.11.118_bib12","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1001\/archinte.164.22.2409","article-title":"Medical vs surgical management of spinal epidural abscess","volume":"164","author":"Siddiq","year":"2004","journal-title":"Arch Intern Med"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018326688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018326688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:13:10Z","timestamp":1761811990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875018326688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":12,"alternative-id":["S1878875018326688"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2018.11.118","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid Progression of Metastatic Panspinal Epidural Non\u2212Small Cell Lung Cancer After Discontinuation of Alectinib","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2018.11.118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}